嵌合肽Pal-DMPOP的设计和阻断免疫检查点CD47/SIRPα与PD-1/PD-L1的作用机制示意图 (IMAGE) Science China Press Caption Pal-DMPOP由CD47/SIRPα的阻断肽、PD-1/PD-L1的D肽阻断剂,以及N端的棕榈酸尾巴和linker组成,该设计能让Pal-DMPOP抵抗血清中酶的降解,并具有肿瘤组织的靶向能力。Pal-DMPOP通过阻断CD47/SIRPα与PD-1/PD-L1增强巨噬细胞的吞噬能力,通过阻断PD-1/PD-L1增强T细胞的杀伤呢能力。 Credit ©《中国科学》杂志社 Usage Restrictions Use with credit. License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.